BMC Infectious Diseases

official impact factor 2.83

Open Access Email this article to a friend

Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]

Oguz Karabay*, Irfan Sencan, Derya Kayas and Idris Şahin

BMC Infectious Diseases 2004, 4:18 doi:10.1186/1471-2334-4-18

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.